AI summaries are provided for informational purposes only and do not replace professional medical advice.
Quick Answer: Clinical trials show that Ozempic (semaglutide) can lead to meaningful weight loss, with many patients losing 5% to 15% of their body weight over 6 to 12 months. Results vary widely by person, dose, and how long treatment continues. Ozempic is approved in Canada for type 2 diabetes; weight loss is a common reported effect.
Ozempic has become one of the most talked-about medications in recent years. Originally developed to treat type 2 diabetes, it has gained widespread attention for its weight-loss effects. Many people in Canada are curious about what kind of results they can realistically expect, and whether the medication is right for them.
This article looks at the reported weight-loss outcomes associated with Ozempic, explains what the clinical data actually shows, and helps you understand what these results mean in the real world. It also clarifies the important distinction between Ozempic and Wegovy, and how these medications are regulated in Canada.
Ozempic is the brand name for semaglutide, a medication manufactured by Novo Nordisk. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic the action of a natural hormone called GLP-1, which is involved in blood sugar regulation and appetite control.
In Canada, Ozempic is approved by Health Canada for the treatment of type 2 diabetes. It is given as a once-weekly injection. While weight loss is a well-documented effect of the medication, it is important to understand that Ozempic’s approved indication is for managing blood sugar in people with type 2 diabetes.
Ozempic works through several mechanisms that contribute to weight loss:
Semaglutide acts on receptors in the brain that regulate appetite. It increases feelings of fullness and reduces hunger, which leads to a natural reduction in calorie intake.
GLP-1 receptor agonists slow the rate at which food leaves the stomach. This prolongs the feeling of fullness after a meal and reduces the urge to eat.
By helping the body use insulin more effectively, Ozempic improves blood sugar control. This can reduce cravings and the energy crashes that often lead to overeating.
Together, these effects help people eat less and feel satisfied with smaller portions, which leads to gradual and sustained weight loss.
Clinical trials have reported a range of weight-loss outcomes for semaglutide. The results depend on the dose, the duration of treatment, and the population being studied.
In studies of people with type 2 diabetes taking Ozempic, average weight loss has ranged from about 5% to 10% of body weight over 6 to 12 months. For a person weighing 200 pounds, a 5% to 10% loss would translate to 10 to 20 pounds.
It is important to note that these are averages. Some people lose more, and some lose less. Individual results vary widely based on factors such as starting weight, diet, physical activity, and how the person responds to the medication.
Both Ozempic and Wegovy contain the same active ingredient, semaglutide. The key difference is the approved indication and the dose.
Because Wegovy uses higher doses, it is associated with greater average weight loss. In clinical trials, Wegovy has been associated with average weight loss of around 15% of body weight over 68 weeks.
It is important to understand that Ozempic is not approved for weight loss on its own in Canada. Using it for weight loss without a type 2 diabetes diagnosis would be an off-label use, which should only be considered under the guidance of a healthcare provider.
The clinical evidence for semaglutide is strong. In the landmark STEP trials, which studied Wegovy (high-dose semaglutide), participants lost an average of about 15% of their body weight over 68 weeks. A significant proportion of participants lost more than 20% of their body weight.
For Ozempic specifically, the SUSTAIN trials studied the medication in people with type 2 diabetes. These trials reported average weight loss of around 5% to 10%, with the higher doses producing greater weight loss.
These results are meaningful. Even a 5% weight loss is associated with improvements in blood pressure, blood sugar, and cholesterol. A 10% to 15% weight loss can have even more significant health benefits.
It is important to interpret these results carefully. Here are some key points to keep in mind:
Weight loss with Ozempic is gradual, not rapid. Most people lose weight steadily over several months. This is generally considered healthier and more sustainable than rapid weight loss.
The medication works best when taken consistently and combined with a healthy diet and regular physical activity. It is not a magic solution that works on its own.
Everyone responds differently. Some people lose a lot of weight, while others lose less. This does not mean the medication is not working; it simply reflects individual differences.
When people stop taking semaglutide, they often regain some of the weight they lost. This is because the appetite-suppressing effects of the medication wear off. Long-term weight management may require ongoing treatment and lifestyle changes.
Like all medications, Ozempic can cause side effects. The most common ones affect the digestive system and include:
These side effects are most common when starting the medication or when the dose is increased. They often improve over time as the body adjusts.
There are also more serious side effects that require medical attention, including:
You should discuss the risks and benefits of Ozempic with your healthcare provider before starting treatment.
Ozempic is not suitable for everyone. You should not take it if you:
Your healthcare provider will review your medical history to determine whether Ozempic is safe for you.
In Canada, Ozempic is available by prescription only. It is given as a once-weekly injection using a pre-filled pen. The dose is typically started low and increased gradually to reduce side effects.
Because it is a prescription medication, you must obtain it through a licensed healthcare provider and a licensed pharmacy. It is not available over the counter.
Health Canada regulates all medications sold in Canada, including Ozempic. It reviews the safety, efficacy, and quality of drugs before they are approved for sale. It also issues product monographs, which provide the official, approved information about how a drug should be used.
The Health Canada product monograph for Ozempic is an important resource for healthcare providers and patients. It contains detailed information about the drug’s indications, dosing, warnings, and side effects.
Ozempic is associated with meaningful weight loss, with many people losing 5% to 15% of their body weight over several months. However, results vary widely, and the medication works best when combined with a healthy lifestyle.
It is important to understand that Ozempic is approved in Canada for type 2 diabetes, not for weight loss on its own. If you are considering Ozempic or any GLP-1 medication for weight management, speak with a healthcare provider to understand whether it is appropriate for you and what results you can realistically expect.
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a licensed healthcare provider before starting any new medication.
We specialize in Men’s Health.
Themd.ca service is FREE for patients in British Columbia with a valid health number.
For patients located elsewhere in Canada, we provide virtual consultation for men’s health if you are in Alberta, Ontario, New Brunswick, Nova Scotia and Yukon for a flat fee of $40.00. This is changing, so please visit our website for any updates and changes.
Add "Kama Health Pharmacy" on the preferred pharmacy field to lock in affordable medications
